SCHEMBL2442849

SCHEMBL2442849

CCNc1ccc2c(=O)c3ccc(N)cc3oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 3/20 0.56
HPGD P15428 3/20 0.56
HSD17B10 Q99714 3/20 0.56
CASP1 P29466 2/20 0.56
CASP7 P55210 2/20 0.56
POLB P06746 1/20 0.56
RECQL P46063 1/20 0.56
RAB9A P51151 6/20 0.47
NPC1 O15118 5/20 0.47
MAPT P10636 3/20 0.47
GFER P55789 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
GAA P10253 2/20 0.45
CA1 P00915 1/20 0.45
GLA P06280 1/20 0.45
RAD52 P43351 1/20 0.44
SRC P12931 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885375 0.91 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL31613986 0.80 RAB9A (0.69) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL1937499 0.80 RAB9A (0.69) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL2435278 0.78 MAPT (0.55) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL11618318 0.74 RAB9A (0.85) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL5191043 0.74 MAOB (0.68) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL3884307 0.73 SMN1; SMN2 (0.56) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL1034943 0.73 CA12 (0.72) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL29673209 0.73 CA12 (0.72) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL3880364 0.73 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF RXFP1, RXFP2, CX3CR1 KDM4E 4545/4885ALDH1A1 91/4885HPGD 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.